Bai C, Zheng Y, Sun M, Ying J, et al. Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial. Eur J Cancer 2025;230:115808.
PMID: 41005213